Minuteman Press Franchise in Boksburg Acquires 31-Year Business Wilpro Printers, Biggest Acquisition for Minuteman Press in South Africa

Minuteman Press Franchise in Boksburg Acquires 31-Year Business Wilpro Printers, Biggest Acquisition for Minuteman Press in South Africa GlobeNewswire January 07, 2026 BOKSBURG, South Africa, Jan. 07, 2026 (GLOBE NEWSWIRE) — Barry Pottinger owns the Minuteman Press franchise in Boksburg, Gauteng, South Africa since May of 2004. To kick off the New Year, Barry completed […]

Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of [⁶⁸Ga]Ga-PentixaFor in treatment-resistant hypertension and Primary Aldosteronism Type B pre-IND meeting provided non-binding guidance on key statistical and methodological aspects, enabling refinement of the Phase 3 study design Feedback clarifies evidence requirements relevant to a

Vicore Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

STOCKHOLM, SE / ACCESS Newswire / January 7, 2026 / Vicore Pharma Holding AB (Nasdaq Stockholm:VICO)(STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference: Location: Westin St. Francis, San Francisco, USA Format:

B2BROKER’s Report Is Live: 63% Brokers Launch with Integrated Stack in Just 10 Days

DUBAI, The United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — B2BROKER, a global fintech solutions provider for financial institutions, unveiled its Fintech Market Report 2025. Drawing from proprietary client data, the report reveals an interesting shift in how brokers build and scale trading operations: 63% now launch with a fully integrated stack combining CRM,

B2BROKER’s Report Is Live: 63% Brokers Launch with Integrated Stack in Just 10 Days

B2BROKER's Report Is Live: 63% Brokers Launch with Integrated Stack in Just 10 Days GlobeNewswire January 07, 2026 DUBAI, The United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — B2BROKER, a global fintech solutions provider for financial institutions, unveiled its Fintech Market Report 2025. Drawing from proprietary client data, the report reveals an interesting shift

Vetted Prop Firms Partners with SabioTrade to Unlock Exclusive Crypto Prop Trading Opportunities

New York , Jan. 07, 2026 (GLOBE NEWSWIRE) — Vetted Prop Firms, a leading independent review and comparison platform for proprietary trading firms, has announced a new strategic partnership with SabioTrade, aimed at delivering exclusive crypto prop trading deals and enhanced transparency for traders worldwide. This partnership marks another step in Vetted Prop Firms' mission

Vetted Prop Firms Partners with SabioTrade to Unlock Exclusive Crypto Prop Trading Opportunities

Vetted Prop Firms Partners with SabioTrade to Unlock Exclusive Crypto Prop Trading Opportunities GlobeNewswire January 07, 2026 New York , Jan. 07, 2026 (GLOBE NEWSWIRE) — Vetted Prop Firms, a leading independent review and comparison platform for proprietary trading firms, has announced a new strategic partnership with SabioTrade, aimed at delivering exclusive crypto prop trading

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections

(SWX:BSLN.SW),(Boerse Stuttgart – Freiverkehr:BSLN),(Boerse Berlin – Freiverkehr:BSLN),(Boerse Frankfurt – Freiverkehr:BSLN),(Boerse Muenchen – Freiverkehr:BSLN), Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with Prokaryotics Inc., a privately held US-based biopharmaceutical company engaged

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections GlobeNewswire January 07, 2026 Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with

HIVE Digital Technologies Delivers Strong Year-Over-Year, Quarter-Over-Quarter and Month-Over-Month Growth, Maintaining over 2% of the Global Bitcoin Network

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025. San Antonio, Texas–(Newsfile Corp. – January 7, 2026) – HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (BVC: HIVECO) (the “Company” or

Scroll to Top